SHOSHANA KOSMAN: Open Payments
NPI 1245892660 · SANTA BARBARA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,115 in 47 payments from 17 companies in 2025. Trend: 2023 $742 · 2024 $948 · 2025 $1,115
Food & beverage: $1,106Education: $10
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 6 | $249 |
| LEO Pharma Inc. | 6 | $150 |
| ABBVIE INC. | 9 | $145 |
| Incyte Corporation | 4 | $109 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 3 | $80 |
| Verrica Pharmaceuticals Inc. | 1 | $67 |
| Amgen Inc. | 3 | $65 |
| Organon LLC | 5 | $48 |
| STRATA Skin Sciences, Inc. | 2 | $36 |
| UCB, Inc. | 1 | $32 |
Products named: DUPIXENT, SKYRIZI, ADBRY, OPZELURA, ILUMYA, YCANTH, OTEZLA, XTRAC.
Industry payments across CA — which companies pay providers there.
